PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 47 filers reported holding PROFOUND MED CORP in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,352,296 | -24.3% | 1,164,125 | -0.4% | 0.22% | -20.4% |
| Q2 2023 | $14,990,781 | +38.2% | 1,168,275 | -0.3% | 0.28% | +37.4% |
| Q1 2023 | $10,850,288 | -14.1% | 1,171,775 | -0.7% | 0.20% | -10.6% |
| Q4 2022 | $12,624,409 | +151.9% | 1,180,425 | -6.0% | 0.23% | +129.3% |
| Q3 2022 | $5,011,000 | -43.6% | 1,255,675 | +0.1% | 0.10% | -36.9% |
| Q2 2022 | $8,890,000 | -24.0% | 1,255,025 | -3.4% | 0.16% | -10.3% |
| Q1 2022 | $11,701,000 | +26.1% | 1,299,125 | +58.0% | 0.18% | +31.6% |
| Q4 2021 | $9,279,000 | -22.3% | 822,250 | +0.5% | 0.13% | -23.1% |
| Q3 2021 | $11,941,000 | -9.7% | 817,975 | +0.9% | 0.17% | -1.7% |
| Q2 2021 | $13,227,000 | -19.6% | 811,075 | -1.1% | 0.18% | -21.4% |
| Q1 2021 | $16,443,000 | -4.7% | 819,900 | -2.4% | 0.22% | -5.1% |
| Q4 2020 | $17,262,000 | +2028.5% | 839,700 | +1725.4% | 0.24% | +1715.4% |
| Q3 2020 | $811,000 | – | 46,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 196,924 | $3,474,000 | 8.11% |
| Gagnon Advisors, LLC | 277,252 | $4,891,000 | 3.00% |
| GAGNON SECURITIES LLC | 779,533 | $13,751,000 | 2.93% |
| Taylor Wealth Management Partners | 166,364 | $2,935,000 | 1.34% |
| AWM Investment Company, Inc. | 348,939 | $6,155,000 | 1.01% |
| PCJ Investment Counsel Ltd. | 121,560 | $2,137,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $13,769,000 | 0.71% |
| Parkman Healthcare Partners LLC | 70,000 | $1,235,000 | 0.33% |
| Park West Asset Management LLC | 450,000 | $7,938,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $12,260,000 | 0.30% |